Maladie de Basedow : aspects thérapeutiques et évolutifs

Bennour, M.; Rojbi, I.; Rezgani, I.; Naçef, I. Ben; Mchirgui, N.; Khiari, K.

doi:10.1016/j.ando.2017.07.416

Search citation statements

Order By: Relevance

Paper Sections

Select...

 the Activity Of Radioactive Iodine Administered1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Similar averages of activity werefound in Tunisian studies by Ben Sellem D et al 15 mCi [15], de Hebaili N et al [32] 15 mCi, de Bennour M et al [34] 13.95 mCi et I. Oueslati et al [30] 13.86 mCi. Open Journal of Biophysics Lower means were described by El Feleh E et al 12.34 mCi [35], N. El Yaagoubi [18] 11.13 mCi and N. Charfi et al, 6 mCi.…”

Section:  the Activity Of Radioactive Iodine Administeredsupporting

confidence: 79%

Iodine 131 Treatment in Graves’ Disease in a West African Country: Preliminary Study about 25 Cases in Senegal

Bathily,

Badiane,

Djigo

et al. 2024

OJBIPHY

View full text Add to dashboard Cite

57Open Journal of Biophysics than 18 months in 92%. The empirically used iodine-131 activity averaged 15.35 mCi. Oral corticosteroid therapy was prescribed in 7 patients for the prevention of malignant orbitopathy. No early side effects were noted. The remission rate at 3 months was 52% and at 6 months was 88% to 92%. Conclusion: The effectiveness of radioactive iodine, in particular ablative doses in the treatment of hyperthyroidism, is no longer to be demonstrated. Taking into account our socioeconomic context, iratherapy should be a treatment of choice for hyperthyroidism with a good quality/price ratio and excellent tolerance.

show abstract